Vis enkel innførsel

dc.contributor.authorBalcik, Burcu
dc.contributor.authorYucesoy, Ecem
dc.contributor.authorAkca, Berna
dc.contributor.authorKarakaya, Sirma
dc.contributor.authorGevsek, Asena Ayse
dc.contributor.authorBaharmand, Hossein
dc.contributor.authorSgarbossa, Fabio
dc.date.accessioned2023-01-09T07:24:01Z
dc.date.available2023-01-09T07:24:01Z
dc.date.created2022-08-04T09:18:08Z
dc.date.issued2022
dc.identifier.issn0020-7543
dc.identifier.urihttps://hdl.handle.net/11250/3041719
dc.description.abstractGiven the scarcity of COVID-19 vaccines, equitable (fair) allocation of limited vaccines across the main administrative units of a country (e.g. municipalities) has been an important concern for public health authorities worldwide. In this study, we address the equitable allocation of the COVID-19 vaccines inside countries by developing a novel, evidence-based mathematical model that accounts for multiple priority groups (e.g. elderly, healthcare workers), multiple vaccine types, and regional characteristics (e.g. storage capacities, infection risk levels). Our research contributes to the literature by developing and validating a model that proposes equitable vaccine allocation alternatives in a very short time by (a) minimising deviations from the so-called ‘fair coverage’ levels that are computed based on weighted pro-rata rations, and (b) imposing minimum coverage thresholds to control the allocation of vaccines to higher priority groups and regions. To describe the merits of our model, we provide several equity and effectiveness metrics, and present insights on different allocation policies. We compare our methodology with similar models in the literature and show its better performance in achieving equity. To illustrate the performance of our model in practice, we perform a comprehensive numerical study based on actual data corresponding to the early vaccination period in Turkey.en_US
dc.language.isoengen_US
dc.publisherTaylor & Francisen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleA Mathematical Model for Equitable In-country COVID-19 Vaccine Allocationen_US
dc.title.alternativeA Mathematical Model for Equitable In-country COVID-19 Vaccine Allocationen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.source.journalInternational Journal of Production Researchen_US
dc.identifier.doi10.1080/00207543.2022.2110014
dc.identifier.cristin2041065
dc.relation.projectNorges forskningsråd: 312773en_US
dc.relation.projectUniversitetet i Agder: 464989en_US
cristin.ispublishedtrue
cristin.fulltextpostprint
cristin.qualitycode2


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal